Hypoglycemia episodes after biliopancreatic diversion for morbid obesity: clinical case presentation
https://doi.org/10.14341/2071-8713-3864
Abstract
Modifications of glucose metabolism are observed after bariatric surgery and are attributed to the increased release of incretins – biologically active gut peptides. Hypoglycemia episodes after bypass operations are mostly of functional origin (dumping syndrome) and can be corrected by dietary recommendations. At the same time multiple cases of nesidioblastosis in patients, who underwent gastric bypass surgery are reported. This article is focused on a clinical case of postprandial hypoglycemia in patient after biliopancreatic diversion for morbid obesity
References
1. Akimov V, et al. A new view on pathogenesis of dumping-syndrome. Vestn Khir II Grek. 2008; 167: 22–5.
2. Anlauf M, et al. Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol. 2005; 29: 524–33.
3. Baggio L, et al. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007; 132: 2131–57.
4. Bantle J, et al. Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg. 2007; 17: 592–4.
5. Beckman L, et al. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. J Parenter Enteral Nutr. 2011; 35: 169–180.
6. Bendix F, et al. Weight loss and changes in salivary ghrelin and adiponectin: Comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding. Obes Surg 2011; doi:10-1007/sl1695-011-0374-5.
7. Bernard B, et al. Hypoglycaemia following upper gastrointestinal surgery: case report and review of the literature. BMC Gastroenterology. 2010; 10: 77.
8. Brechner R, et al. A graded evidence-based summary of evidence for bariatric surgery. Surg Obes Relat Dis. 2005; 1: 430–441.
9. Buchwald H, et al. Metabolic bariatric surgery Worldwide 2008. Obes Surg. 2009; 19: 1605–11.
10. Bult M. et al. Surgical treatment of obesity. Eur J Endocrinol. 2008; 158 (2): 135–45.
11. Clancy T et al. Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg. 2006; 10: 1116–9.
12. Clifton P. Bariatric surgery: results in obesity and effects on metabolic parameters. Current Opinion in Lipidology. 2011; 22: 1–5.
13. Cui Y, et al. Advances in the Etiology and Management of Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass. J Gastrointest Surg. 2011; 15: 1879–88.
14. Deitel M. The change in the dumping syndrome concept. Obes Surg. 2008; 18: 1622–4.
15. Dirksen C et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia. 2012; 55: 1890–901.
16. Edholm T, et al. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterology & Motility. 2010; 22, 1191–1200, e315.
17. Goldfine A, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin responses to a mixed meal. J Clin Endocrinol Metab. 2007; 92: 4678–85.
18. Heber D, et al. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010; 95(11): 4823–43.
19. Heinlein C. Dumping Syndrome in Roux-en-Y Bariatric Surgery Patients: Are They Prepared? Bariatric nursing and surgical patient care. 2009; 4(1): 39–47.
20. Holst J. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87:1409–1439
21. Kim S, et al. Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. Obes Surg. 2009; 19: 1550–1556.
22. Lamounier R, et al. Incretins: clinical physiology and bariatric surgery- correlating the entero-endocrine system and a potentially anti-dysmetabolic procedure. Obes Surg. 2007; 17: 569–76.
23. le Roux C, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006; 243: 108–14.
24. Marsk R, et al. Nationwide cohort study of post-gastric bypass hypoglycemia including 5,040 patients undergoing surgery for obesity in 1986–2006 in Sweden. Diabetologia. 2010; 53: 2307–11.
25. Mason E, Gastric emptying controls type 2 diabetes mellitus (Editorial). Obes Surg. 2007; 17: 853–5.
26. McLaughlin T, et al. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab. 2010; 95: 1851–5.
27. Mechanick J, et al. AACE/TOS/ASMBS Guidelines. Surgery for Obesity and Related Diseases. 2008; 4: S109–84.
28. Neary M, et al. Gut hormones: implications for the treatment of obesity. Pharmacology & Therapeutics. 2009; 124: 44–56.
29. Patti M, et al. Hypoglycaemia following gastric bypass surgery:diabetes remission in the extreme? Diabetologia. 2010; 53: 2276–2279.
30. Patti M, et al. Severe hypoglycaemia postgastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia. 2005; 48: 2236–40.
31. Rabiee A, et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: Unraveling the roles of gut hormonal and pancreatic endocrine dysfunction. J Surg Res. 2011; 167: 199–205.
32. Rubino F, et al. The early effect of Roux-en-Y gastric bypass on hormones is involved in body weight regulation and glucose metabolism. Ann Surg. 2004; 240: 236–242.
33. Scavini M, et al. Asymptomatic hyperinsulinemic hypoglycemia after gastric banding. N Engl J Med. 2005; 353: 2822–2823.
34. Service G, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric bypass surgery. N Engl J Med. 2005; 353: 249–54.
35. Thaler J, et al. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009; 150: 2518–25.
36. Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract. 2005; 20: 517–25.
37. Vella A, et al. Incretin hypersecretion in postgastric bypass hypoglycemia: primary problem or red herring? J Clin Endocrinol Metab. 2007; 92: 4563–5.
38. Vidal J, et al. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab. 2009; 94: 884–91.
39. World Health Organization. Web site [Internet]. Geneva (Switzerland): World Health Organization; 2006. Obesity and overweight. Fact sheet No.311; [cited 2007 Oct 1]. Available from:www.who.int/mediacentre/factsheets/fs311/en/index.html.
Review
For citations:
, , , , Hypoglycemia episodes after biliopancreatic diversion for morbid obesity: clinical case presentation. Obesity and metabolism. 2013;10(3):44-49. (In Russ.) https://doi.org/10.14341/2071-8713-3864
Views:
326
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
